NASDAQ
Algorae Pharmaceuticals Limited (LVCLF) has a free cash flow growth of -729588.63% as of Friday, May 29, 2026. This represents a 1352638.75% decrease compared to its 12-month average of 53.94%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.